Testing Vision Is Not Testing For Vision.

gene therapy optogenetic prosthetic vision sensory substitution spatial perception stem cell vision restoration visual perception

Journal

Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919

Informations de publication

Date de publication:
12 2020
Historique:
received: 17 04 2020
accepted: 02 11 2020
entrez: 1 1 2021
pubmed: 2 1 2021
medline: 15 5 2021
Statut: epublish

Résumé

Visual prostheses aim to restore, at least to some extent, vision that leads to the type of perception available for sighted patients. Their effectiveness is almost always evaluated using clinical tests of vision. Clinical vision tests are designed to measure the limits of parameters of a functioning visual system. I argue here that these tests are rarely suited to determine the ability of prosthetic devices and other therapies to restore vision. This paper describes and explains many limitations of these evaluations. Prosthetic vision testing often makes use of multiple-alternative forced-choice (MAFC) procedures. Although these paradigms are suitable for many studies, they are frequently problematic in vision restoration evaluation. Two main types of problems are identified: (1) where nuisance variables provide spurious cues that can be learned in repeated training, which is common in prosthetic vision, and thus defeat the purpose of the test; and (2) even though a test is properly designed and performed, it may not actually measure what the researchers believe, and thus the interpretation of results is wrong. Examples for both types of problems are presented. Additional problems arise from confounding factors in the administration of tests are pointed as limitations of current device evaluation. For example, head tracing of magnified objects enlarged to compensate for the system's low resolution, in distinction from the scanning head (camera) movements with which users of prosthetic devices expand the limited field of view. Because of these problems, the ability to perform satisfactorily on the clinical tests is necessary but insufficient to prove vision restoration, therefore, additional tests are needed. I propose some directions to pursue in such testing. Numerous prosthetic devices are being developed and introduced to the market. Proving the utility of these devices is crucial for regulatory and even for post market acceptance, which so far has largely failed, in my opinion. Potential reasons for the failures despite success in regulatory testing and directions for designing improved testing are provided. It is hoped that improved testing will guide improved designs of future prosthetic systems and other vision restoration approaches.

Identifiants

pubmed: 33384886
doi: 10.1167/tvst.9.13.32
pii: TVST-20-2525
pmc: PMC7757632
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Pagination

32

Subventions

Organisme : NEI NIH HHS
ID : P30 EY003790
Pays : United States

Informations de copyright

Copyright 2020 The Authors.

Déclaration de conflit d'intérêts

Disclosure: E. Peli, has two patents and a patent application on image processing for visual prostheses, all assigned to the Schepens Eye Research Institute

Références

Invest Ophthalmol Vis Sci. 2003 Dec;44(12):5362-9
pubmed: 14638739
J Integr Neurosci. 2005 Dec;4(4):505-21
pubmed: 16385644
J Neural Eng. 2018 Oct;15(5):055003
pubmed: 29781807
Optom Vis Sci. 2002 Sep;79(9):569-80
pubmed: 12322927
Transl Vis Sci Technol. 2021 Aug 12;10(10):8
pubmed: 34383874
Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):792-802
pubmed: 29392324
Invest Ophthalmol Vis Sci. 2010 Feb;51(2):1255-60
pubmed: 19850846
Behav Res Methods. 2015 Dec;47(4):1122-1135
pubmed: 25582810
Vision Res. 2018 Nov;152:40-50
pubmed: 29258869
Proc Biol Sci. 2013 Feb 20;280(1757):20130077
pubmed: 23427175
Vision Res. 2015 Jun;111(Pt B):182-96
pubmed: 25448710
Nat Med. 2018 Oct;24(10):1507-1512
pubmed: 30297895
Sci Rep. 2015 Oct 22;5:15628
pubmed: 26490260
Proc Biol Sci. 1999 Dec 7;266(1436):2427-33
pubmed: 10643086
Proc Biol Sci. 2000 Nov 7;267(1458):2231-8
pubmed: 11413637
Clin Exp Ophthalmol. 2017 Mar;45(2):152-159
pubmed: 27495262
PLoS One. 2012;7(3):e33136
pubmed: 22438894
J Neural Eng. 2014 Apr;11(2):020301
pubmed: 24556526
Vision Res. 2001 Nov;41(24):3145-61
pubmed: 11711140
Vision Res. 2015 Mar;108:77-84
pubmed: 25637855
Optom Vis Sci. 2018 May;95(5):452-456
pubmed: 29683989
Int J Artif Intell Tools. 2009 Jun;18(3):415-438
pubmed: 20161188
Transl Vis Sci Technol. 2018 Oct 29;7(5):29
pubmed: 30386681
Neuron. 2012 Nov 8;76(3):640-52
pubmed: 23141074
Prog Retin Eye Res. 2013 Sep;36:1-23
pubmed: 23500412
J Opt Soc Am. 1971 Jan;61(1):1-11
pubmed: 5541571
JAMA Pediatr. 2019 May 1;173(5):446-454
pubmed: 30907929
PLoS One. 2021 Feb 10;16(2):e0229189
pubmed: 33566851
Nature. 2009 Oct 8;461(7265):784-7
pubmed: 19759534
J Opt Soc Am A. 1991 Apr;8(4):625-36
pubmed: 2045967
Vision Res. 2015 Jun;111(Pt B):149-60
pubmed: 25812924
Ophthalmology. 2020 Aug;127(8):1097-1104
pubmed: 32249038
Vision Res. 2016 Sep;126:264-277
pubmed: 26525845
Transl Vis Sci Technol. 2020 Jul 16;9(8):25
pubmed: 32864194
IEEE Trans Biomed Eng. 1992 Feb;39(2):112-21
pubmed: 1612614
J Vis. 2015;15(13):22
pubmed: 26418498
Span J Psychol. 2019 Dec 23;22:E56
pubmed: 31868158
Invest Ophthalmol Vis Sci. 2012 May 04;53(6):2720-31
pubmed: 22447863

Auteurs

Eli Peli (E)

Schepens Eye Research Institute of Mass Eye & Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH